Shareholders Approve Reverse Stock Split and Massive Increase in Authorized Shares

summarizeSummary

Modular Medical shareholders approved a reverse stock split to regain Nasdaq compliance and significantly increased authorized common stock, paving the way for substantial future dilution.

check_boxKey Events

• Reverse Stock Split Approved

  Shareholders approved an amendment to the Articles of Incorporation to effect a reverse stock split, with the board of directors having discretion on the ratio and timing within one year. This follows the DEF 14A filing on January 8, 2026, which sought this approval to regain Nasdaq compliance.

• Authorized Shares Significantly Increased

  The company's authorized common stock was increased from 100,000,000 shares to 250,000,000 shares, representing a 150% increase in potential share count.

• Equity Incentive Plan Expanded

  Shareholders approved an amendment to the 2017 Equity Incentive Plan, increasing the number of shares reserved for issuance by 3,000,000.

• Directors Elected

  All nominated candidates were elected to serve as directors until the next annual meeting of shareholders.

auto_awesomeAnalysis

The approval of a reverse stock split is a critical step for Modular Medical to regain compliance with Nasdaq's minimum bid price requirement, following the proposal outlined in the DEF 14A filing on January 8, 2026. While necessary for continued listing, reverse splits often reflect underlying financial challenges and can be viewed negatively by investors. Concurrently, the substantial increase in authorized common stock from 100 million to 250 million shares, alongside an additional 3 million shares for the equity incentive plan, creates a significant potential for future dilution. This indicates the company's need for capital and flexibility, but also suggests a challenging financial outlook.